Hester Biosciences Limited (HESTERBIO) - Total Liabilities
Based on the latest financial reports, Hester Biosciences Limited (HESTERBIO) has total liabilities worth Rs3.24 Billion INR (≈ $35.06 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore HESTERBIO shareholders equity momentum to track the company's year-over-year net asset growth rate.
Hester Biosciences Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Hester Biosciences Limited's total liabilities have evolved over time, based on quarterly financial data. See Hester Biosciences Limited free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Hester Biosciences Limited Competitors by Total Liabilities
The table below lists competitors of Hester Biosciences Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Teamlease Services Limited
NSE:TEAMLEASE
|
India | Rs17.41 Billion |
|
Asiacement
KO:183190
|
Korea | ₩1.06 Trillion |
|
Real Asset Acquisition Corp.
NASDAQ:RAAQ
|
USA | $7.00 Million |
|
Acsion Ltd
JSE:ACS
|
South Africa | ZAC4.76 Billion |
|
Rani Zim Shopping Centers
TA:RANI
|
Israel | ILA2.51 Billion |
|
Kukdo Chemical
KO:007690
|
Korea | ₩873.18 Billion |
|
AudioCodes Ltd
TA:AUDC
|
Israel | ILA158.06 Million |
|
Pizza Pizza Royalty Corp.
TO:PZA
|
Canada | CA$75.61 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Hester Biosciences Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Hester Biosciences Limited market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.06 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.96 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hester Biosciences Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hester Biosciences Limited (2006–2025)
The table below shows the annual total liabilities of Hester Biosciences Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs3.27 Billion ≈ $35.33 Million |
-9.11% |
| 2024-03-31 | Rs3.59 Billion ≈ $38.88 Million |
+41.84% |
| 2023-03-31 | Rs2.53 Billion ≈ $27.41 Million |
-14.02% |
| 2022-03-31 | Rs2.95 Billion ≈ $31.88 Million |
+68.35% |
| 2021-03-31 | Rs1.75 Billion ≈ $18.94 Million |
-1.63% |
| 2020-03-31 | Rs1.78 Billion ≈ $19.25 Million |
+50.46% |
| 2019-03-31 | Rs1.18 Billion ≈ $12.79 Million |
+19.44% |
| 2018-03-31 | Rs990.40 Million ≈ $10.71 Million |
+5.43% |
| 2017-03-31 | Rs939.35 Million ≈ $10.16 Million |
+18.21% |
| 2016-03-31 | Rs794.66 Million ≈ $8.59 Million |
+4.74% |
| 2015-03-31 | Rs758.73 Million ≈ $8.21 Million |
+15.08% |
| 2014-03-31 | Rs659.34 Million ≈ $7.13 Million |
+19.44% |
| 2013-03-31 | Rs552.05 Million ≈ $5.97 Million |
+60.64% |
| 2012-03-31 | Rs343.66 Million ≈ $3.72 Million |
-16.39% |
| 2011-03-31 | Rs411.02 Million ≈ $4.45 Million |
+2.43% |
| 2010-03-31 | Rs401.26 Million ≈ $4.34 Million |
+5.95% |
| 2009-03-31 | Rs378.73 Million ≈ $4.10 Million |
+7.68% |
| 2008-03-31 | Rs351.73 Million ≈ $3.80 Million |
-2.00% |
| 2007-03-31 | Rs358.92 Million ≈ $3.88 Million |
+307.05% |
| 2006-03-31 | Rs88.17 Million ≈ $953.58K |
-- |
About Hester Biosciences Limited
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl… Read more